Tilray Brands, Inc. Non Peo Neo Avg Total Comp Amt
Tilray Brands, Inc. (TLRY) reported Non Peo Neo Avg Total Comp Amt of $3.43 million for the 12-month period ending 2026-05-31, per its PRE 14A filed 2026-09-18.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-09-18
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2026-05-31 | $3.43M PRE 14A · filed 2026-09-18 |
| 2025-05-31 | $1.99M PRE 14A · filed 2026-09-18 |
| 2024-05-31 | $2.06M PRE 14A · filed 2026-09-18 |
| 2023-05-31 | $2.37M PRE 14A · filed 2026-09-18 |
| 2022-05-31 | $2.76M PRE 14A · filed 2026-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |